Suzawa, K., Toyooka, S., Sakaguchi, M., Morita, M., Yamamoto, H., Tomida, S., . . . Miyoshi, S. (2015). Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations. John Wiley and Sons Inc.
Chicago Style CitationSuzawa, Ken, et al. Antitumor Effect of Afatinib, As a Human Epidermal Growth Factor Receptor 2‐targeted Therapy, in Lung Cancers Harboring HER2 Oncogene Alterations. John Wiley and Sons Inc, 2015.
MLA CitationSuzawa, Ken, et al. Antitumor Effect of Afatinib, As a Human Epidermal Growth Factor Receptor 2‐targeted Therapy, in Lung Cancers Harboring HER2 Oncogene Alterations. John Wiley and Sons Inc, 2015.
Warning: These citations may not always be 100% accurate.